190 related articles for article (PubMed ID: 20109744)
1. Vaccinia virus-specific molecular signature in atopic dermatitis skin.
Grigoryev DN; Howell MD; Watkins TN; Chen YC; Cheadle C; Boguniewicz M; Barnes KC; Leung DY
J Allergy Clin Immunol; 2010 Jan; 125(1):153-159.e28. PubMed ID: 20109744
[TBL] [Abstract][Full Text] [Related]
2. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.
Freyschmidt EJ; Mathias CB; MacArthur DH; Laouar A; Narasimhaswamy M; Weih F; Oettgen HC
J Allergy Clin Immunol; 2007 Mar; 119(3):671-9. PubMed ID: 17336617
[TBL] [Abstract][Full Text] [Related]
3. Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.
Oyoshi MK; Beaupré J; Venturelli N; Lewis CN; Iwakura Y; Geha RS
J Allergy Clin Immunol; 2015 Jun; 135(6):1511-8.e6. PubMed ID: 25649082
[TBL] [Abstract][Full Text] [Related]
4. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.
Scott JE; ElKhal A; Freyschmidt EJ; MacArthur DH; McDonald D; Howell MD; Leung DY; Laouar A; Manjunath N; Bianchi T; Boes M; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2007 Dec; 120(6):1382-8. PubMed ID: 17889291
[TBL] [Abstract][Full Text] [Related]
5. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.
Howell MD; Gallo RL; Boguniewicz M; Jones JF; Wong C; Streib JE; Leung DY
Immunity; 2006 Mar; 24(3):341-8. PubMed ID: 16546102
[TBL] [Abstract][Full Text] [Related]
6. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.
Howell MD; Gao P; Kim BE; Lesley LJ; Streib JE; Taylor PA; Zaccaro DJ; Boguniewicz M; Beck LA; Hanifin JM; Schneider LC; Hata TR; Gallo RL; Kaplan MH; Barnes KC; Leung DY
J Allergy Clin Immunol; 2011 Nov; 128(5):1006-14. PubMed ID: 21762972
[TBL] [Abstract][Full Text] [Related]
7. Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus.
Kim BE; Leung DY; Streib JE; Kisich K; Boguniewicz M; Hamid QA; Howell MD
J Allergy Clin Immunol; 2007 Feb; 119(2):457-63. PubMed ID: 17141855
[TBL] [Abstract][Full Text] [Related]
8. Specificity protein 1 is pivotal in the skin's antiviral response.
Bin L; Howell MD; Kim BE; Streib JE; Hall CF; Leung DY
J Allergy Clin Immunol; 2011 Feb; 127(2):430-438.e1-2. PubMed ID: 21208652
[TBL] [Abstract][Full Text] [Related]
9. IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum.
Darling AR; Freyschmidt EJ; Burton OT; Koleoglou KJ; Oyoshi MK; Oettgen HC
Clin Immunol; 2014 Feb; 150(2):153-60. PubMed ID: 24412909
[TBL] [Abstract][Full Text] [Related]
10. Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.
Freyschmidt EJ; Mathias CB; Diaz N; MacArthur DH; Laouar A; Manjunath N; Hofer MD; Wurbel MA; Campbell JJ; Chatila TA; Oettgen HC
J Immunol; 2010 Jul; 185(2):1295-302. PubMed ID: 20548030
[TBL] [Abstract][Full Text] [Related]
11. Eczema vaccinatum.
Reed JL; Scott DE; Bray M
Clin Infect Dis; 2012 Mar; 54(6):832-40. PubMed ID: 22291103
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.
Oyoshi MK; Elkhal A; Kumar L; Scott JE; Koduru S; He R; Leung DY; Howell MD; Oettgen HC; Murphy GF; Geha RS
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14954-9. PubMed ID: 19706451
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain.
Bin L; Howell MD; Kim BE; Hall CF; Streib JE; Leung DY
J Allergy Clin Immunol; 2009 Aug; 124(2):270-7, 277.e1. PubMed ID: 19577285
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.
Howell MD; Jones JF; Kisich KO; Streib JE; Gallo RL; Leung DY
J Immunol; 2004 Feb; 172(3):1763-7. PubMed ID: 14734759
[TBL] [Abstract][Full Text] [Related]
15. Growth of herpes simplex type 1 on skin explants of atopic eczema.
Goodyear HM; Davies JA; McLeish P; Buchan A; Skinner GR; Winther M; Harper JI
Clin Exp Dermatol; 1996 May; 21(3):185-9. PubMed ID: 8914357
[TBL] [Abstract][Full Text] [Related]
16. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.
Beck LA; Boguniewicz M; Hata T; Schneider LC; Hanifin J; Gallo R; Paller AS; Lieff S; Reese J; Zaccaro D; Milgrom H; Barnes KC; Leung DY
J Allergy Clin Immunol; 2009 Aug; 124(2):260-9, 269.e1-7. PubMed ID: 19541356
[TBL] [Abstract][Full Text] [Related]
17. Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus.
Brewer MG; Monticelli SR; Moran MC; Miller BL; Beck LA; Ward BM
Cells; 2022 Apr; 11(8):. PubMed ID: 35456017
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity.
Becker Y
Virus Genes; 2003 Dec; 27(3):269-82. PubMed ID: 14618088
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.
Kawakami Y; Tomimori Y; Yumoto K; Hasegawa S; Ando T; Tagaya Y; Crotty S; Kawakami T
J Exp Med; 2009 Jun; 206(6):1219-25. PubMed ID: 19468065
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.
Bin L; Edwards MG; Heiser R; Streib JE; Richers B; Hall CF; Leung DY
J Allergy Clin Immunol; 2014 Oct; 134(4):848-55. PubMed ID: 25159465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
